These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11309777)

  • 1. Prognostic significance of combined conventional and immunocytochemical cytology for peritoneal washings in endometrial carcinoma.
    Luo ML; Sakuragi N; Shimizu M; Seino K; Okamoto K; Kaneuchi M; Ebina Y; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Cancer; 2001 Apr; 93(2):115-23. PubMed ID: 11309777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.
    Kasamatsu T; Onda T; Katsumata N; Sawada M; Yamada T; Tsunematsu R; Ohmi K; Sasajima Y; Matsuno Y
    Br J Cancer; 2003 Jan; 88(2):245-50. PubMed ID: 12610496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 overexpression as a prognostic indicator in endometrial carcinoma.
    Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G
    Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53 in imprint smears of endometrial carcinoma.
    Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.
    Ohkouchi T; Sakuragi N; Watari H; Nomura E; Todo Y; Yamada H; Fujimoto S
    Am J Obstet Gynecol; 2002 Aug; 187(2):353-9. PubMed ID: 12193924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.
    Tanaka K; Kobayashi Y; Sugiyama J; Yamazaki T; Dozono K; Watanabe M; Shibuya H; Nishigaya Y; Momomura M; Matsumoto H; Umezawa S; Takamatsu K; Iwashita M
    Int J Clin Oncol; 2017 Jun; 22(3):533-540. PubMed ID: 28083737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
    Ivanov S; Tomov S
    Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent prognostic value of peritoneal immunocytodiagnosis in endometrial carcinoma.
    Benevolo M; Mariani L; Vocaturo G; Vasselli S; Natali PG; Mottolese M
    Am J Surg Pathol; 2000 Feb; 24(2):241-7. PubMed ID: 10680892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma.
    Powell B; Soong R; Grieu F; Knowles S; Hammond I; Iacopetta B
    Int J Oncol; 1999 Jan; 14(1):175-9. PubMed ID: 9863026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?
    Saga Y; Imai M; Jobo T; Kuramoto H; Takahashi K; Konno R; Ohwada M; Suzuki M
    Gynecol Oncol; 2006 Oct; 103(1):277-80. PubMed ID: 16678244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
    Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
    Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
    Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
    Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature.
    Shiozaki T; Tabata T; Yamada T; Yamamoto Y; Yamawaki T; Ikeda T
    Int J Gynecol Cancer; 2014 Mar; 24(3):549-55. PubMed ID: 24476896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.
    Lee B; Suh DH; Kim K; No JH; Kim YB
    Jpn J Clin Oncol; 2016 Aug; 46(8):711-7. PubMed ID: 27207885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study.
    Athanassiadou P; Athanassiades P; Grapsa D; Gonidi M; Athanassiadou AM; Stamati PN; Patsouris E
    Int J Gynecol Cancer; 2007; 17(3):697-704. PubMed ID: 17504383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.